U.S. market Open. Closes in 5 hours 12 minutes

CNCR | Loncar Cancer Immunotherapy ETF Holdings

(Stock Exchange: NASDAQ)
Symbol Name Market Cap Weight Valuation Profitability Growth Health 200SMA Price Change IV IV Rank
TIL Instil Bio, Inc. 113.29M 3.59%
17.36 -3.98% 576.12% 75.97%
REPL Replimune Group, Inc. 750.89M 3.54%
9.75 -6.16% 122.01% 15.94%
IOVA Iovance Biotherapeutics, Inc. 1.09B 3.47%
3.33 -6.46% 70.61% 30.68%
ZYME Zymeworks Inc. 828.66M 3.45%
11.91 -3.72% 291.26% 53.33%
ARGX argenx SE 35.96B 3.42%
591.87 0.46% 31.77% 34.01%
GMAB Genmab A/S 12.46B 3.42%
19.58 -1.61% 74.56% 33.21%
AZN AstraZeneca PLC 227.94B 3.39%
73.50 -0.39% 30.00% 74.03%
BMY Bristol-Myers Squibb Company 124.10B 3.39%
60.99 1.62% 39.10% 100.05%
CRSP CRISPR Therapeutics AG 2.92B 3.39%
34.03 -8.00% 65.44% 77.15%
MRK Merck & Co., Inc. 226.74B 3.37%
89.76 0.59% 38.46% 98.43%
NKTR Nektar Therapeutics 126.55M 3.37%
0.6800 -7.90% 288.36% 59.96%
XNCR Xencor, Inc. 749.71M 3.37%
10.64 -5.25% 81.40% 81.36%
REGN Regeneron Pharmaceuticals, Inc. 68.18B 3.36%
634.23 -0.49% 44.03% 94.27%
FATE Fate Therapeutics, Inc. 90.54M 3.33%
0.7901 -6.97% 236.51% 64.93%
GILD Gilead Sciences, Inc. 139.54B 3.33%
112.05 0.23% 32.76% 76.20%
RCUS Arcus Biosciences, Inc. 830.85M 3.32%
7.85 -3.92% 286.49% 39.02%
ATRA Atara Biotherapeutics, Inc. 34.80M 3.30%
5.94 -9.04% 769.79% 94.72%
ALLO Allogene Therapeutics, Inc. 317.21M 3.29%
1.4600 -5.81% 677.77% 57.74%
RUBY Rubius Therapeutics, Inc. 3.29%
TRIL Trillium Therapeutics Inc. 3.29%
BLUE bluebird bio, Inc. 47.54M 3.28%
4.88 19.61% 122.15% 7.08%
IBRX ImmunityBio, Inc. 2.57B 3.28%
3.01 -4.14% 162.94% 34.84%
IMAB I-Mab 29.20M 3.25%
0.8239 -2.07% 546.25% N/A
IGMS IGM Biosciences, Inc. 68.38M 3.23%
1.1500 -7.26% 187.84% 100.00%
STTK Shattuck Labs, Inc. 45.36M 3.23%
0.9501 -9.94% 586.39% 69.64%
ALXO ALX Oncology Holdings Inc. 33.26M 3.21%
0.6230 -4.90% 270.19% 38.96%
LEGN Legend Biotech Corporation 3.12B 3.20%
33.93 -3.22% 65.05% 26.80%
BGNE BeiGene, Ltd. 3.19%
MGNX MacroGenics, Inc. 80.12M 3.17%
1.2700 0.79% 120.94% 33.32%
YMAB Y-mAbs Therapeutics, Inc. 200.32M 3.12%
4.43 -7.90% 299.13% 43.09%
Cash&Other 0.13%
Total holdings: 31 Recognized Stocks: 27 Others: 4
An error has occurred. This application may no longer respond until reloaded. Reload 🗙